title: Intragastric nitric oxide/nitrite in Helicobacter pylori-infected subjects.
abstract: BACKGROUND
  Nitrite (NO2-) in swallowed saliva is reduced to nitric oxide (NO) and other nitrogen oxides by the intragastric acidity. This mechanism is probably important for the intragastric clearance of ingested micro-organisms and nitrosating compounds. The study examines the balance between intragastric NO and NO2- in relation to endogenous acid production and infection with Helicobacter pylori.
  
  
  METHODS
  Six healthy H. pylori-negative and six H. pylori-positive volunteers with no known gastroduodenal pathology were examined after an overnight fast. Gastric NO was measured using a chemiluminescence technique and pH as well as NO2- were analysed in gastric aspirates.
  
  
  RESULTS
  Gastric NO was slightly lower in H. pylori-positive subjects (1560 +/- 211 ppb) than in uninfected controls (2112 +/- 430 ppb; P > 0.05) during basal conditions, whereas both pH and NO2- concentration were similar in the two groups. During inhibition of acid secretion (omeprazole 20 mg b.i.d. over 5 days) median pH and mean NO2- concentration in gastric aspirates were significantly higher in H. pylori positives than in the controls. Furthermore, during omeprazole treatment the intragastric NO levels were almost absent in H. pylori positives, whereas approximately 50% remained in H. pylori-negative individuals.
  
  
  CONCLUSIONS
  Proton-pump inhibition in H. pylori-infected individuals abolishes the intragastric chemical reduction of swallowed NO2- in the fasting stomach.
authors.affiliation: Dept. of Surgery, Göteborg University, Sweden. Lars.Fandriks@surgery.gu.se
authors.forename: L
authors.initials: L
authors.lastname: Fändriks
authors.forename: C
authors.initials: C
authors.lastname: von Bothmer
authors.forename: A
authors.initials: A
authors.lastname: Aneman
authors.forename: L
authors.initials: L
authors.lastname: Olbe
authors.forename: A
authors.initials: A
authors.lastname: Pettersson
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000032:analysis; D005260:Female; D005744:Gastric Acid / Q000737:chemistry*; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000378:metabolism*; D016480:Helicobacter pylori / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D006863:Hydrogen-Ion Concentration / Q000187:drug effects; D008297:Male; D009569:Nitric Oxide / Q000032:analysis / Q000378:metabolism*; D009853:Omeprazole / Q000008:administration & dosage*; D011336:Probability; D012016:Reference Values; D012463:Saliva / Q000737:chemistry* / Q000187:drug effects; D018709:Statistics, Nonparametric
chemical_list: D015415:Biomarkers; D009569:Nitric Oxide; D009853:Omeprazole